Authentic Heroes To Supply Personal Protective Equipment To Front Line Service Providers

    NEXT STORY
    Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path to FDA EUA, and Commercialization
    PREV STORY
    ALK announces Health Canada approval of ITULATEK SLIT-tablets for the treatment of tree pollen allergy
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Clinicians Discuss Positive Impact of T2MR Platform on Sepsis Care at IDWeek 2017

    LEXINGTON, Mass., Oct. 12, 2017 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging ...

    author_avatar
    NASDAQ Market News

    Ziopharm Oncology to Host Conference Call to Discuss Second Quarter 2019 Results on August 8, 2019

    author_avatar
    NASDAQ Market News

    Updated TACTI-mel Data Presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit

    SYDNEY, Australia, March 22, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ:IMMP) (“Immutep” or ...

    author_avatar
    NASDAQ Market News